VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IBEXIBEX Limited
$30.08$405M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIBEXCash Flow

IBEX Limited (IBEX) Cash Flow Statement

10Y historyFree accessUpdated daily

Cash flow generation remains inconsistent, with the OCF/NI ratio fluctuating between 0.12 and 2.91, and liquidity is constrained by a cash balance that declined to $15.4M in 2026Q3 from $62.7M in 2024Q4.

IBEX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16
Cash from Operations62.12M45.67M35.9M41.86M40.01M16.08M51.72M2.2M-5.75M6.65M3.04M
Operating CF Margin %-8.18%7.06%8%8.12%3.63%12.77%0.6%-1.68%1.99%0.94%
Operating CF Growth %678.92%27.21%-14.24%4.63%148.84%-68.91%2248.73%138.32%-186.47%118.47%-
Net Income47.18M36.86M33.66M31.58M21.46M13.09M7.77M19.41M-15.94M-8.72M3.43M
Depreciation & Amortization18.55M17.23M19.46M18.98M18.1M14.12M24.47M21.8M12.42M13.83M12.65M
Stock-Based Compensation158K5.43M3.77M4.61M1.85M5.36M359K5.26M8.94M323K945K
Deferred Taxes-1.96M-2.88M344K4.53M-5.17M-1.91M0-13.44M-6.24M-1.72M1.84M
Other Non-Cash Items-5.54M15.32M15.95M15.85M15.04M12.41M11.51M13.38M5.33M6.39M5.13M
Working Capital Changes-23.54M-26.3M-37.28M-33.69M-11.27M-26.98M7.61M-44.22M-10.26M-3.46M-20.96M
Change in Receivables-9.57M-19.26M0-12.3M-9.71M-13.33M9.04M-18.02M758K4.01M-20.04M
Change in Inventory00000000000
Change in Payables9.29M6.25M-2.25M-3.75M2.31M-4.01M09M4.41M2.34M7.49M
Cash from Investing-29.8M-18.38M-8.86M-19.04M-25.92M-20.82M-4.83M-9.08M-5.44M-9.75M-11.58M
Capital Expenditures-29.8M-18.38M-8.86M-18.95M-25.92M-20.82M-4.28M-6.23M-5.76M-9.93M-10.88M
CapEx % of Revenue4.75%3.29%1.74%3.62%5.26%4.7%1.06%1.69%1.68%2.97%3.37%
Acquisitions000-85K000-3.04M182K177K178K
Investments-----------
Other Investing000000-552K810K715K177K178K
Cash from Financing-29.69M-74.66M-21.73M-13.61M-22.13M40.9M-33.87M2.55M3.19M14.98M12.19M
Debt Issued (Net)-20.25M-953K-543K-15.39M-18.76M-17.16M-19.2M10.12M3.33M15.76M18.61M
Equity Issued (Net)-11.26M-78.01M-21.56M-276K-3.41M63.11M0-5.97M025K-59K
Dividends Paid00000-4M0-1.6M-146K-1M-6.56M
Share Repurchases-11.73M-78.01M-21.56M-276K-3.41M00-5.97M00-118K
Other Financing1.82M4.31M366K2.05M35K-1.05M-14.67M00190K200K
Net Change in Cash2.43M-47.37M5.29M8.6M-9.01M35.97M13M-4.65M-7.8M11.87M3.65M
Free Cash Flow32.31M27.29M27.05M22.91M14.09M-4.75M47.44M-4.03M-11.51M-3.29M-7.84M
FCF Margin %5.15%4.89%5.32%4.38%2.86%-1.07%11.71%-1.09%-3.36%-0.98%-2.43%
FCF Growth %63.88%0.92%18.06%62.61%396.82%-110.01%1276.49%64.98%-250.44%58.09%-
FCF per Share2.151.741.481.210.75-0.262.68-0.23-0.65-0.19-0.44
FCF Conversion (FCF/Net Income)0.68x1.24x1.07x1.33x1.86x1.23x6.66x-0.49x0.36x-0.74x1.94x
Interest Paid913K1.63M514K152K1.25M09.43M0000
Taxes Paid-2.78M11.95M7.69M4.28M2.16M000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality and Cash Conversion

Based on reported financial statements, IBEX exhibits significant volatility in cash conversion, with the OCF/NI ratio fluctuating from a low of 0.12 in 2025Q2 to a high of 2.91 in 2025Q4, suggesting that net income is frequently decoupled from actual cash generation capabilities.

The wide variance in the conversion ratio indicates that reported net income is heavily influenced by non-cash items and timing differences in revenue recognition. Investors should monitor whether this inconsistency stems from aggressive accrual accounting or the inherent lumpiness of BPO contract billing cycles.

Free Cash Flow Margin Instability

As indicated by the quarterly data, IBEX's free cash flow trajectory remains inconsistent, with margins swinging from a negative 3.4% in 2024Q2 to a peak of 15.5% in 2025Q4, reflecting a business model that struggles to maintain steady cash flow generation across different periods.

The inability to sustain positive free cash flow suggests that the company's operational scaling is often offset by sudden cash outflows. This pattern warrants further investigation into whether the company's growth strategy is fundamentally cash-consumptive or if these dips are merely temporary timing mismatches.

Working Capital Drag on Liquidity

According to recent SEC filings, IBEX consistently faces substantial working capital outflows, with a recurring negative impact on operating cash flow that reached a peak drain of $17.7M in 2024Q2, highlighting a persistent challenge in managing the cash conversion cycle effectively.

The recurring negative working capital changes suggest that the company is likely extending significant credit to clients or facing delays in collections that outpace its ability to manage payables. This persistent drain on cash flow may indicate a lack of bargaining power with larger enterprise customers.

Aggressive Capital Allocation Amidst Constraints

Based on reported figures, IBEX has prioritized share repurchases, including a notable $46.6M outflow in 2025Q2, despite maintaining a relatively modest cash position, which suggests a management strategy that favors returning capital to shareholders over building a larger liquidity buffer for operational contingencies.

The decision to allocate significant capital to buybacks while operating cash flow remains volatile may limit the company's flexibility to invest in proprietary technology or weather potential sector downturns. Investors should monitor whether this capital allocation strategy is sustainable given the company's reliance on external growth.

IBEX — Frequently Asked Questions

Quick answers to the most common questions about buying IBEX stock.

How much cash does IBEX Limited (IBEX) generate from operations?

IBEX Limited (IBEX) generated $45.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is IBEX Limited's free cash flow?

IBEX Limited (IBEX) generated $27.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is IBEX Limited's capital expenditure (CapEx)?

IBEX Limited (IBEX) spent $18.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does IBEX Limited distribute cash to shareholders?

In 2025, IBEX Limited (IBEX) spent $78.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.